Want China Times, Xinhua 2013-06-14
Following repeated product recalls in China, the China Food and Drug Administration on Thursday called for pharmaceutical giant Johnson & Johnson to strengthen quality management.
Johnson & Johnson's company logo. (Photo/CFP) |
Following repeated product recalls in China, the China Food and Drug Administration on Thursday called for pharmaceutical giant Johnson & Johnson to strengthen quality management.
The
administration's figures show that the company has issued 33 recall orders
since 2009, with the most recent two recalls made on April 23 and May 3 over
the quality of their drug products.
"Frequent
recalls over quality concerns reflect possible flaws in the quality management
system of Johnson & Johnson, and the company should carefully look into the
sources of the issue...eliminate safety risks and ensure the quality of
products for the market," said a statement released by the administration
on Thursday.
The
administration stressed that the company's China-based subsidiaries and their
range of products for the Chinese market must strictly abide by the country's
law and technological requirements, and any quality issues must be reported to
supervision departments in a timely manner.
"The
nature and causes of a quality issue as well as ensuing risk control measures
to be taken should be disclosed to the public honestly," the statement
said, vowing strengthened supervision over the company.
Meanwhile,
the administration urged all China-based pharmaceutical enterprises to put
product quality as a priority and take immediate action to recall products with
quality defects while releasing relevant information to supervision departments
as well as the public.
The
administration vowed "harsh measures," including banning the
manufacture and sale of products in China, for companies responsible for late
or secret product recalls.
No comments:
Post a Comment